Press Releases June 3, 2026 08:32 AM

Quantum X Labs Appoints Prof. Oren Raz of the Weizmann Institute of Science to Its Scientific Advisory Board

Quantum X Labs Adds Leading Quantum Thermodynamics Expert Prof. Oren Raz to Enhance Scientific Leadership as Company Advances Fault-Tolerant Quantum Computing

By Maya Rios QXL

Quantum X Labs Inc. (NASDAQ: QXL) announces the appointment of Prof. Oren Raz of the Weizmann Institute of Science to its Scientific Advisory Board. Prof. Raz is recognized for his expertise in non-equilibrium quantum thermodynamics, a key area for advancing quantum computing hardware. His addition supports the company's efforts in scaling its neutral-atom platform, validating patented AI-driven error correction technology, and expanding into aerospace and defense quantum sensing markets.

Quantum X Labs Appoints Prof. Oren Raz of the Weizmann Institute of Science to Its Scientific Advisory Board
QXL

Key Points

  • Quantum X Labs strengthens its scientific leadership with renowned physicist Prof. Oren Raz joining the advisory board.
  • Company advances its AI-driven error correction architecture (patent US12294387B2) aimed at fault-tolerant quantum computing.
  • Expansion into aerospace and defense quantum sensing markets signals growth beyond computing into high-value sectors.

World-Renowned Expert in Non-Equilibrium Quantum Thermodynamics and Quantum Dynamics Joins QXL's Scientific Leadership as the Company Scales Toward Fault-Tolerant Quantum Computing.

Tel Aviv, Israel, June 03, 2026 (GLOBE NEWSWIRE) -- Quantum X Labs Inc. (Nasdaq: QXL), an advanced quantum technologies company, today announces the appointment of Prof. Oren Raz of the Weizmann Institute of Science to its Scientific Advisory Board. Prof. Raz's appointment brings one of Israel's most distinguished physicists into the company's scientific leadership at a pivotal moment in QXL's development — as it scales its neutral-atom platform, validates its patented AI-driven error correction architecture (US12294387B2), and expands into aerospace and defense quantum sensing markets.

Prof. Oren Raz is a faculty member in the Department of Physics of Complex Systems at the Weizmann Institute of Science, Rehovot, Israel — one of the world's foremost scientific research institutions. His research is focused on non-equilibrium physical systems — from life to lasers — that operate far from thermal equilibrium, a domain of fundamental importance to the practical operation of quantum computing hardware.

Prof. Raz's published work has accumulated over 2,600 citations, reflecting the breadth and impact of his contributions across quantum physics, statistical mechanics, and quantum information

"Prof. Raz's work is the science that tells us what happens inside a qubit when things get hard — when coherence is fragile, when the system is far from equilibrium, when standard assumptions break down” says Prof. Nir Sharon, Quantum X Labs Chief Scientist “Having him on our Scientific Advisory Board means we are making decisions about our hardware, our error correction, and our sensing platforms with one of the world's best minds in quantum thermodynamics in our corner."

About Quantum X Labs:

Quantum X Labs Inc. and its subsidiaries are focused on quantum technology, digital advertising and computing and enterprise artificial intelligence (AI) solutions. Quantum X Labs Ltd. is focused on developing and promoting quantum algorithms for the transportation, drug discovery and security segments as well as developing quantum- based GPS replacement and quantum atom accuracy solutions. Gix Media develops a variety of technological software solutions, which perform automation, optimization and monetization of internet campaigns, for the purposes of acquiring and routing internet user traffic to its customers. Metagramm is a developer of grammatical error correction software and offers tools for writing and reviewing, grammar, spelling, punctuation and style features, as well as translation and multilingual dictionaries, using artificial intelligence and machine learning technology.

For more information about Quantum X Labs, visit https://quantumxlabs.xyz/

Forward-Looking Statements

This press release contains forward-looking statements within the meaning of the “safe harbor” provisions of the Private Securities Litigation Reform Act of 1995 and other Federal securities laws. Forward-looking statements contained in this press release include, but are not limited to, statements regarding Quantum X Labs’ and its subsidiaries’ strategic and business plans, technology, relationships, objectives and expectations for its business, growth, the impact of trends on and interest in its business, intellectual property, products and its future results, operations and financial performance and condition and may be identified by the use of words such as “may,” “seek,” “will,” “consider,” “likely,” “assume,” “estimate,” “expect,” “anticipate,” “intend,” “believe,” “do not believe,” “aim,” “predict,” “plan,” “project,” “continue,” “potential,” “guidance,” “objective,” “outlook,” “trends,” “future,” “could,” “would,” “should,” “target,” “on track” or their negatives or variations, and similar terminology and words of similar import, generally involve future or forward-looking statements. For example, the Company is using forward-looking statements when it discusses the anticipated contributions of Prof. Oren Raz. Forward-looking statements are not historical facts, and are based upon management’s current expectations, beliefs and projections, many of which, by their nature, are inherently uncertain. Such expectations, beliefs and projections are expressed in good faith. However, there can be no assurance that management’s expectations, beliefs and projections will be achieved, and actual results may differ materially from what is expressed in or indicated by the forward-looking statements. Forward-looking statements are subject to risks and uncertainties that could cause actual performance or results to differ materially from those expressed in the forward-looking statements. For a more detailed description of the risks and uncertainties affecting the Company, reference is made to the Company’s reports filed from time to time with the Securities and Exchange Commission (“SEC”), including, but not limited to, the risks detailed in the Company’s most recent Annual Report on 10-K and in subsequent filings with the SEC. Forward-looking statements speak only as of the date the statements are made. The Company assumes no obligation to update forward-looking statements to reflect actual results, subsequent events or circumstances, changes in assumptions or changes in other factors affecting forward-looking information except to the extent required by applicable securities laws. If the Company does update one or more forward-looking statements, no inference should be drawn that the Company will make additional updates with respect thereto or with respect to other forward-looking statements. References and links to websites have been provided as a convenience, and the information contained on such websites is not incorporated by reference into this press release. ParaZero is not responsible for the content of third-party websites. 

Investor Relations Contacts:

Michal Efraty
Investor Relations
[email protected] 


Risks

  • The forward-looking statements highlight risks including uncertainty in achieving technological milestones and market expansion.
  • Quantum computing hardware development faces inherent technical challenges that may delay productization and commercialization.
  • Dependence on successful integration of new technologies and maintaining competitive edge in a rapidly evolving quantum technology sector.

More from Press Releases

Verizon declares quarterly dividend on June 4, 2026 Jun 4, 2026 AmperCap Acquisition Company Completes its $125,000,000 Initial Public Offering Jun 4, 2026 Algoma Steel Releases 2025 Sustainability Report Jun 4, 2026 SOLV Energy Announces Full Exercise and Closing of Underwriters’ Option to Purchase Additional Shares of Class A Common Stock Jun 4, 2026 NRx Pharmaceuticals, Inc. Announces Closing of $22.3 Million Public Offering of Common Stock and Including Exercise of the Underwriters’ Option Jun 4, 2026